timoth
Joined 12 years ago
Joined 12 years ago
It's very unlikely people would need to mess about with MittId/BankID if they can't use card payments at a market. Firstly, if they're doing the almost-unheard-of clunky approach of using their mobile banking app to make a bank transfer, it would probably be authorised using their touch/face ID instead of BankID/MittID. But far more likely, they'd use one of the ubiquitous mobile payment apps: Vipps (Norway), Swish (Sweden) or MobilePay (Denmark).
(By the way, I believe EGPWS would take priority over TCAS anyway.)
I thought they were generally still in effect. The multiple UK and non-UK networks I'm aware of still allow free roaming across UK and EU etc.
It immediately goes on to talk about their own discovery 10 years ago that prions could be spread through aerosols which "totally shocked" them and might "warrant re-thinking on prion biosafety guidelines" but that seems an entirely separate thing from the decision to use only sheep prions for research.
> she stabbed her left thumb with a curved forceps while cleaning a cryostat — a machine that can cut tissues at very low temperatures — that she used to slice brain sections from transgenic mice infected with a sheep-adapted form of BSE
Then later:
> Aguzzi declined to comment on the French CJD cases, but told Science his lab never handles human or bovine prions for research purposes, only for diagnostics. "We conduct research only on mouse-adapted sheep prions, which have never been shown to be infectious to humans," Aguzzi says.
Am I missing something, or is the logical conclusion that Aguzzi thinks his lab is avoiding disaster by only using mouse-adapted sheep prions, but the lady is suspected to have been infected by an injury related to "transgenic mice infected with a sheep-adapted form of BSE". I hope there's some nuance here, because otherwise it sounds like Aguzzi's lab isn't actually avoiding infection. Perhaps the lady's case isn't considered to have definitely confirmed infectiousness due to uncertainty (though no uncertainty seemed to be mentioned)? Or the mouse-adapted sheep prions Aguzzi's lab uses are different to the transgenic mice infected with a sheep-adapted form of BSE? I have no idea; it's just that the apparent conflict between these two sections jumped out to my layman's eyes.
Using the account regional namespace is also described as a security best practice:
> Creating buckets in your account regional namespace is a security best practice. These bucket names can only ever be used by your account. You can create buckets in your account regional namespace to easily template general purpose bucket names across multiple AWS Regions. You can have assurance that no other account can create bucket names in your namespace. If another account attempts to create a bucket with your account regional suffix, the CreateBucket request will be rejected.
https://docs.aws.amazon.com/AmazonS3/latest/userguide/gpbuck...